Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Aurora Cannabis

Aphria

Canopy Growth

Could the reasons behind Aphria's dismal Q3 results bite Aurora Cannabis, Canopy Growth, and others in their next quarterly updates?

What Aphria's Poor Performance Could Mean for Other Canadian Marijuana Stocks

Tilray Brands

Without a company name attached to these metrics, are pot stocks really an attractive investment opportunity?

Can You Guess the Identity of These Marijuana Stocks?

HEXO Corp

Quest Diagnostics' Drug Testing Index highlights a potentially worrisome trend.

Should We Blame Marijuana for a 14-Year High in Positive Work-Related Drug Tests?

Profits could be a lot tougher to come by than investors realize.

Earnings Estimates Are Tumbling for These Pot Stocks

Two out of three Americans favor legalizing marijuana. So, why hasn't that happened yet?

Why Is Legalizing Pot Proving So Difficult in the United States?

Cronos group, a vertically integrated Canadian marijuana company, has seen its stock price rise close to 3x over the last year, driven by the legalization of recreational pot in Canada and also by a $1.8 billion investment from Marlboro cigarette maker Altria group.

What Are The Key Risks Cronos Group Faces?

Scotts Miracle-Gro

Cannabis stocks had a huge showing on Wall Street this past fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them. Some of the stocks even doubled or tripled in value in this time.

Short Sellers Getting Higher on Cannabis Stocks

Altria

Which stock wins in a matchup between these two Canadian cannabis producers?

Better Marijuana Stock: Cronos Group vs. The Green Organic Dutchman

Company performance driven by opening up of U.S. CBD market.

Charlotte's Web Has Been On A Tear - More To Come

On Oct. 17, 2018, Canada made history by becoming the first G7 country and the second country overall to legalize adult-use cannabis.

Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch

These brand-name pot stocks have some pretty glaring deficiencies.

Here's Why the 5 Most Popular Marijuana Stocks Aren't Worth Buying

With talk of a looming recession, analysts predict that given a downturn there will be a short list of growth industries capable of delivering a healthy return on investment.

5 Key Factors To Consider Before Making A Cannabis Acquisition

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

GW Pharmaceuticals

Innovative Industrial Properties

Village Farms International

Mirror, mirror, on the wall, these were the greenest marijuana stocks of all.

These 14 Pot Stocks Gained at Least 70% in the First Quarter

CannTrust Holdings

Amplify Alternative Harvest ETF

The week brought big cannabis news, with the FDA setting its first hearing regarding CBD's legality in food and drinks for May, and the STATES Act, which aims to protect cannabis businesses and users in legal states from federal intervention, being introduced in Congress.

This Week's Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times

CVS Health

Walgreens

Global CBD sales could soar by 147% annually over the next four years.

9 Things You Must Know About CBD Before Investing in Pot Stocks

Consolidation and equity investments are picking up steam as the green rush takes shape.

The 5 Largest Marijuana Deals in History

Hint: It's not the biggest of the big players.

Which Big Canadian Marijuana Stock Has the Most Upside Potential Right Now?

Sales are soaring, but so are operating losses for most pot stocks.

Marijuana Stock Earnings: A Comprehensive Look at First-Quarter Results

New Age Beverages

The cannabis space cooled down last month, due in part to a spate of quarterly earnings releases that failed to excite investors.

Why Marijuana Stocks Tilray, Cronos, and New Age Beverages Fell 10% to 19% in March

Cronos is the new third-largest pot stock, but it has no business being listed side by side with its larger peers.

Cronos Group Can't Hold a Candle to Aurora Cannabis or Canopy Growth

A ranking of the top marijuana growers by sales in the most recent quarter.

Here's Who Sold the Most Marijuana Last Quarter

These marijuana companies are issuing stock like it's going out of style, and it's shareholders who could pay the price.

Pot Stock Share-Based Dilution: 5 of the Worst Offenders

An industry worth $910 million in 2015 reached $13.8 billion in 2018, and it seems bound only sunward yet: The bottom line is, the sky’s the limit.

For Cannabis Industry Investment, 2018 Was Terrific But 2019 Looks Even Better

Three downgrades following a subpar fourth-quarter earnings report suggest the tide is shifting for this popular pot stock.

Wall Street Is Finally Wising Up on Cronos Group

Two leaders, two laggards, and one in the group of top marijuana stocks that's most likely to succeed in the States.

News for Cronos Group Stock (CRON)